Generic Modified-Release Antiepileptic Drugs: No Difference Within Formulations, but Important Differences Across Formulations

Epilepsy Currents - United States
doi 10.5698/1535-7511-17.1.29
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

Pharmacokinetic Analysis of Modified-Release Metoprolol Formulations: An Interspecies Comparison

European Journal of Pharmaceutical Sciences
Pharmaceutical Science
2017English

Generic Clozapine: Outcomes After Switching Formulations

British Journal of Psychiatry
MedicinePsychiatryMental Health
2006English

Liposome Formulations of Hydrophobic Drugs

Methods in Molecular Biology
GeneticsMolecular Biology
2016English

Development of Controlled Release Formulations of Thiabendazole

Journal of Agricultural Chemistry and Environment
2014English

Access to Liposomal Generic Formulations: Beyond AmBisome and Doxil/Caelyx

GaBI Journal
Drug GuidesPharmacy
2013English

Bioavailability and Dissolution of Proprietary and Generic Formulations of Phenytoin.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1992English

Quality Evaluation of Original and Generic Formulations of Iopamidol Injection

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2007English

Bioanalysis and In-Vivo Studies of Clarithromycin Modified Release Solid Dosage Formulations by Liquid Chromatography-Mass Spectroscopy

International Journal of Research in Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

Review of Extended-Release Formulations of Tramadol for the Management of Chronic Non-Cancer Pain: Focus on Marketed Formulations

Journal of Pain Research
AnesthesiologyPain Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy